SpringWorks Therapeutics

United States
Savoy, Texas, United States, 06902

Company profile

SpringWorks Therapeutics company profile

SpringWorks Therapeutics focuses on developing and commercializing innovative therapies for cancer treatment. The company specializes in targeted oncology, aiming to provide solutions that address unmet medical needs in the oncology space. SpringWorks offers a range of therapies, including those that target specific genetic mutations in tumors. Their research emphasizes precision medicine, utilizing advanced methodologies to enhance treatment efficacy. The company engages in collaborations to accelerate the development of its pipeline and improve patient outcomes in oncology.

Business identity

Contact email
[email protected]
Phone number
203-883-9490
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$10M-$100M
Founded
2017-01-01, Year

Headquarters

Postal code
06902
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
5
Total equity funding
$1B
Last funding
Post IPO Equity / $275M / 2023-12-04
Last equity funding
Post IPO Equity / $275M
Investors
18
Lead investors
1
Founders
2
Articles
281
Exited on
2019-09-12

Founders and investors

Founders

Lara SullivanYoni Falkson

Lead investors

Perceptive Advisors

Investors

Bain CapitalBain Capital Life SciencesOrbiMedPerceptive AdvisorsSamsara BioCapital